ChromoGenics AB
Symbol: CHRO.ST
STO
7
SEKMarktpreis heute
-0.4925
P/E-Verhältnis
0.0000
PEG-Verhältnis
28.87M
MRK Kapital
- 0.00%
DIV Rendite
ChromoGenics AB (CHRO-ST) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 7.9 | 24.1 | 18.9 | ||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.net-receivables | 0 | 11.7 | 11.7 | 13.7 | ||||||||||
balance-sheet.row.inventory | 0 | 10.2 | 10.2 | 11 | ||||||||||
balance-sheet.row.other-current-assets | 0 | 9 | 0.1 | 2.2 | ||||||||||
balance-sheet.row.total-current-assets | 0 | 29.8 | 46 | 45.7 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 98.3 | 103 | 101.8 | ||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0.6 | 1.5 | ||||||||||
balance-sheet.row.intangible-assets | 0 | 10.7 | 11.7 | 9 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 10.7 | 12.3 | 10.5 | ||||||||||
balance-sheet.row.long-term-investments | 0 | 0.4 | 0.4 | 0 | ||||||||||
balance-sheet.row.tax-assets | 0 | -0.4 | 0 | 0 | ||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0.4 | -0.3 | 2.5 | ||||||||||
balance-sheet.row.total-non-current-assets | 0 | 109.4 | 115.5 | 114.8 | ||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 0 | 139.2 | 161.5 | 160.4 | ||||||||||
balance-sheet.row.account-payables | 0 | 2.8 | 8.6 | 7.8 | ||||||||||
balance-sheet.row.short-term-debt | 0 | 0.2 | 0.3 | 15.4 | ||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.long-term-debt-total | 0 | 66.6 | 63.8 | 46.3 | ||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 0 | 24.4 | 15.9 | 3.4 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 66.6 | 66.2 | 50.1 | ||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-liab | 0 | 94 | 91 | 102.7 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.common-stock | 0 | 35.1 | 28.7 | 3.4 | ||||||||||
balance-sheet.row.retained-earnings | 0 | -715.4 | -661.1 | -601.7 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 9.9 | 8.1 | 5.6 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 713.2 | 694.8 | 650.3 | ||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 42.8 | 70.5 | 57.7 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 139.2 | 161.5 | 160.4 | ||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-equity | 0 | 42.8 | 70.5 | 57.7 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||
Total Investments | 0 | 0.4 | 0.4 | 2.5 | ||||||||||
balance-sheet.row.total-debt | 0 | 66.8 | 64.1 | 61.7 | ||||||||||
balance-sheet.row.net-debt | 0 | 58.9 | 40 | 42.8 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -52.5 | -55.9 | -59.7 | ||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 4.5 | 3.4 | 2.3 | ||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.change-in-working-capital | 0 | 4.5 | -5.8 | 2.5 | ||||||||||
cash-flows.row.account-receivables | 0 | 0.1 | 6.1 | -3.8 | ||||||||||
cash-flows.row.inventory | 0 | 0 | 0.8 | -2.8 | ||||||||||
cash-flows.row.account-payables | 0 | -5.8 | 0.8 | -0.4 | ||||||||||
cash-flows.row.other-working-capital | 0 | 10.3 | -13.6 | 9.4 | ||||||||||
cash-flows.row.other-non-cash-items | 0 | 2.7 | -0.9 | -3.9 | ||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -0.1 | -4.9 | -16 | ||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -0.1 | -4.9 | -16 | ||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -0.3 | -0.1 | ||||||||||
cash-flows.row.common-stock-issued | 0 | 24.8 | 69.8 | 0.3 | ||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | 69.5 | 0.2 | ||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 24.8 | 69.5 | 0.2 | ||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.net-change-in-cash | 0 | -16.2 | 5.3 | -74.5 | ||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 7.9 | 24.1 | 18.9 | ||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 24.1 | 18.9 | 93.4 | ||||||||||
cash-flows.row.operating-cash-flow | 0 | -40.8 | -59.3 | -58.8 | ||||||||||
cash-flows.row.capital-expenditure | 0 | -0.1 | -4.9 | -16 | ||||||||||
cash-flows.row.free-cash-flow | 0 | -41 | -64.2 | -74.7 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 13.6 | 18.3 | 24.7 | ||||||||||
income-statement-row.row.cost-of-revenue | 0 | 64.3 | 15 | 15.9 | ||||||||||
income-statement-row.row.gross-profit | 0 | -50.6 | 3.3 | 8.7 | ||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 29 | 25.1 | ||||||||||
income-statement-row.row.operating-expenses | 0 | 55.8 | 60.8 | 69.6 | ||||||||||
income-statement-row.row.cost-and-expenses | 0 | 64.3 | 75.8 | 85.6 | ||||||||||
income-statement-row.row.interest-income | 0 | 0.5 | 0.6 | 0.1 | ||||||||||
income-statement-row.row.interest-expense | 0 | 4.3 | 1.7 | 4 | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -1.9 | 0.6 | -2.7 | ||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 29 | 25.1 | ||||||||||
income-statement-row.row.total-operating-expenses | 0 | -1.9 | 0.6 | -2.7 | ||||||||||
income-statement-row.row.interest-expense | 0 | 4.3 | 1.7 | 4 | ||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 4.5 | 5 | 3.4 | ||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.operating-income | 0 | -50.6 | -57.5 | -60.9 | ||||||||||
income-statement-row.row.income-before-tax | 0 | -52.5 | -57 | -63.5 | ||||||||||
income-statement-row.row.income-tax-expense | 0 | 0 | -0.6 | 3.8 | ||||||||||
income-statement-row.row.net-income | 0 | -52.5 | -56.4 | -67.3 |
Häufig gestellte Frage
Wie hoch ist die ChromoGenics AB (CHRO.ST) Gesamtvermögen?
ChromoGenics AB (CHRO.ST) Gesamtvermögen ist 139163000.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist N/A.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist -0.745.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist -10.337.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist -3.912.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist -3.675.
Was ist der ChromoGenics AB (CHRO.ST) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist -52506000.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 66819999.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 55824000.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 0.000.